MENU
+Compare
LENS
ETF ticker: BATS
AS OF
Jul 3, 02:00 PM (EDT)
Price
$28.17
Change
-$0.06 (-0.21%)

LENS stock forecast, quote, news & analysis

The investment seeks to achieve long-term capital appreciation... Show more

LENS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for LENS with price predictions
Jul 02, 2025

LENS in +1.50% Uptrend, rising for three consecutive days on July 02, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LENS advanced for three days, in of 16 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 5 cases where LENS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on June 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LENS as a result. In of 6 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Exxon Mobil Corp (NYSE:XOM), Chevron Corp (NYSE:CVX), GE Aerospace (NYSE:GE), BHP Group Limited (NYSE:BHP), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), Freeport-McMoran (NYSE:FCX), Vale SA (NYSE:VALE), Cheniere Energy (NYSE:LNG), Diamondback Energy (NASDAQ:FANG), Wheaton Precious Metals Corp (NYSE:WPM).

Industry description

The investment seeks to achieve long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that will invest primarily in domestic and foreign equity securities of companies considered by Sarmaya Partners, LLC, the sub-adviser to the fund (the “Sub-Adviser”), to reflect an emerging or prevailing market theme. The Sub-Adviser defines “emerging or prevailing market theme” as market sectors, asset classes, or regions that are believed to be poised for future growth through the market cycle (i.e, the period of time between two major lows for a market. The fund is non-diversified.

Market Cap

The average market capitalization across the Sarmaya Thematic ETF ETF is 69.18B. The market cap for tickers in the group ranges from 234.86M to 461.22B. XOM holds the highest valuation in this group at 461.22B. The lowest valued company is GTE at 234.86M.

High and low price notable news

The average weekly price growth across all stocks in the Sarmaya Thematic ETF ETF was 8%. For the same ETF, the average monthly price growth was 28%, and the average quarterly price growth was 77%. VALE experienced the highest price growth at 13%, while AR experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the Sarmaya Thematic ETF ETF was 36%. For the same stocks of the ETF, the average monthly volume growth was 33% and the average quarterly volume growth was 107%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 55
Price Growth Rating: 48
SMR Rating: 64
Profit Risk Rating: 35
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
LENS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

an ophthalmic device company

Category ForeignLargeGrowth

Profile
Fundamentals
Details